1. Home
  2. XGN vs DRIO Comparison

XGN vs DRIO Comparison

Compare XGN & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.06

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$8.40

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XGN
DRIO
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.5M
61.8M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
XGN
DRIO
Price
$3.06
$8.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$9.14
$35.00
AVG Volume (30 Days)
289.2K
10.4K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1559.02
EPS
N/A
10.12
Revenue
N/A
$7,394,000.00
Revenue This Year
$8.06
$26.84
Revenue Next Year
$12.93
$44.98
P/E Ratio
N/A
$0.80
Revenue Growth
N/A
43.02
52 Week Low
$2.59
$0.38
52 Week High
$12.23
$17.74

Technical Indicators

Market Signals
Indicator
XGN
DRIO
Relative Strength Index (RSI) 46.86 39.99
Support Level N/A $7.37
Resistance Level $3.79 $9.37
Average True Range (ATR) 0.21 0.81
MACD 0.05 0.07
Stochastic Oscillator 67.14 35.32

Price Performance

Historical Comparison
XGN
DRIO

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Share on Social Networks: